DAWNELLE HOLADIA: Open Payments
NPI 1821613381 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 67 payments from 19 companies in 2025. Trend: 2023 $1,895 · 2024 $1,572 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $228 |
| Novartis Pharmaceuticals Corporation | 15 | $225 |
| BridgeBio Pharma, Inc. | 4 | $188 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $107 |
| Merck Sharp & Dohme LLC | 6 | $96 |
| Novo Nordisk Inc | 4 | $94 |
| SCPHARMACEUTICALS INC. | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
| AngioDynamics, Inc. | 1 | $35 |
Products named: Attruby, LEQVIO, CAMZYOS, Kerendia, VERQUVO, Wegovy, ELIQUIS, FUROSCIX.
Industry payments across NC — which companies pay providers there.
